Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthetic dose optimization for electroconvulsive therapy using propofol, alfentanil, and thiopentone
ACTRN12609000523202Phase 4Not yet recruiting
- Sponsor
- Sanjay Sharma
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol, alfentanil and thiopental in major depressive disorder (MDD) and mental disorder (4 arms), sponsored by Sanjay Sharma. Primary endpoints: Reduction in propofol dose when combined with alfentanil and Seizure duration and quality. Planned start Sep 2009; status: not yet recruiting.
02
Drugs
propofolalfentanilthiopental
03
Conditions
major depressive disorder (MDD)mental disorder
Beyond the preview
Go deeper on ACTRN12609000523202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000523202.